glycyrrhizic acid has been researched along with Elevated Cholesterol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, CH; Hsieh, YL; Lee, YT; Yeh, YH | 1 |
| Fujii, I; Hayashi, H; Hirai, Y; Honda, H; Ikutani, M; Matsunaga, T; Muraguchi, A; Nagai, Y; Okamoto, N; Takatsu, K; Tsuneyama, K; Watanabe, Y | 1 |
| Chen, Y; Li, PL; Li, X; Pitzer, AL; Wang, L; Zhang, Y | 1 |
| Makarova, SI; Nikitin, YP; Ragino, YI; Safronova, OG; Salakhutdinov, NF; Stakhneva, EM; Tolstikov, GA; Vavilin, VA | 1 |
| Lyakhovich, VV; Makarova, SI; Nikitin, YP; Ragino, YI; Safronova, OG; Salakhutdinov, NF; Stakhneva, EM; Tolstikov, GA; Vavilin, VA | 1 |
| FURUYA, K; HATTORI, Y; KOJIMA, O; MATSUSHIMA, S; NAGANO, E; NAITO, H; NAKAMURA, H; SHIMANO, K; YAMAZAKI, A; YOSHIZAWA, O | 1 |
6 other study(ies) available for glycyrrhizic acid and Elevated Cholesterol
| Article | Year |
|---|---|
Ameliorative effect of Pracparatum mungo extract on high cholesterol diets in hamsters.
Topics: Animals; Antioxidants; Berberine; Cholesterol; Cricetinae; Glycyrrhizic Acid; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Liver; Male; Mesocricetus; Phaseolus; Plant Extracts; Receptors, LDL; Sterol Regulatory Element Binding Protein 2 | 2014 |
Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents; Carrier Proteins; Cell Line, Tumor; Chalcones; Diet, High-Fat; DNA-Binding Proteins; Glyburide; Glycyrrhiza uralensis; Glycyrrhizic Acid; Humans; Hypercholesterolemia; Inflammasomes; Inflammation; Insulin Resistance; Interleukin-1beta; Islet Amyloid Polypeptide; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Specific Pathogen-Free Organisms | 2014 |
Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation.
Topics: Acetylcholine; Animals; Bradykinin; Carrier Proteins; Caspase 1; Cholesterol; Coronary Vessels; Cytoskeletal Proteins; Disease Models, Animal; Endothelial Cells; Glycyrrhizic Acid; HMGB1 Protein; Hypercholesterolemia; Inflammasomes; Inflammation; Male; Mice, Inbred C57BL; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Poloxamer; Pyrin; Pyroptosis; Reactive Oxygen Species; Receptors, Cell Surface; Serpins; Superoxides; Vasodilation; Viral Proteins | 2015 |
Study of cholesterol-lowering effect and safety of simvaglisin on rabbit model of hypercholesterolemia.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Creatine Kinase; Disease Models, Animal; Glycyrrhizic Acid; Hypercholesterolemia; Male; Rabbits; Simvastatin | 2008 |
Antioxidant and endothelium-stabilizing effects of simvaglyzin on rabbits with experimental hypercholesterolemia.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Antioxidants; Aryldialkylphosphatase; Cholesterol; Diet; Endothelin-1; Endothelium, Vascular; Fluorometry; Glycyrrhizic Acid; Hypercholesterolemia; Male; Nitrous Oxide; Rabbits; Simvastatin; von Willebrand Factor | 2008 |
[ON CHOLESTEROL-LOWERING AGENTS. 3. CHOLESTEROL-LOWERING EFFECTS OF UNSATURATED FATS, COENZYMATIC PREPARATIONS, AND GLYCYRRHIZIN].
Topics: Antioxidants; Cholesterol; Coenzymes; Fats, Unsaturated; Glycyrrhiza; Glycyrrhizic Acid; Humans; Hypercholesterolemia; Pharmacology | 1963 |